EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Distribution of Female and Male First and Last Authorship across Drug Delivery Related Journals with Respect to Year and Journal Impact Factor

Jacqueline E McLaughlin, Jacob M Bachelder, Kristy M Ainslie iD

Molecular Pharmaceutics · 2023

DOI: 10.1021/acs.molpharmaceut.3c00328 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2023. Verfasst von Jacqueline E McLaughlin und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Practice Advancement and Clinical Education, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North…. Hauptthemen laut MEDLINE: Journal Impact Factor, Periodicals as Topic. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: University of North Carolina.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

First and last authorship are important metrics of productivity and scholarly success for trainees and professors. For 11 drug delivery-related journals in 2021, the percentage of female first (39.5%) and last (25.7%) authorship was reported. A strong negative correlation, with female first (rp = -0.73) and female last authorship (rp = -0.66), was observed with respect to journal impact factor. In contrast, there was a strong positive correlation with male first and last authorship (rp = 0.71). Papers were ∼1.5 times more likely to have a male first author, and ∼3 times more likely to have a male last author, than females. A female was 22% more likely to have first authorship if the last author was female, although there is an ∼1% increase per year in female authorship with male last authorship, which equates to equality in first authorship by 2044. Considering that drug delivery is composed of engineering, chemistry, and pharmaceutical science disciplines, the observed 25.7% female last authorship does not represent the approximately 35.5% to 50% of professors that are female in these disciplines, internationally. Overall, female authorship in drug delivery-related journals should improve to better represent the work of female senior authors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Journal Impact FactorPeriodicals as TopicMaleHumansFemaleAuthorship

Stichwörter der Autor:innen

biomedical engineeringgenderpeer reviewpharmaceuticspublicationswomen

Autor:innen und Institutionen

  • Division of Practice Advancement and Clinical Education, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States.
  • Carborro High School, Chapel Hill, North Carolina 27599, United States.
  • Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States.
  • Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill and North Carolina State University, Chapel Hill, North Carolina 27599, United States.
  • Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States.

ORCID-Profile: Kristy M Ainslie

Förderung

  • University of North Carolina

Zitieren

APA

McLaughlin, J. E., Bachelder, J. M., & Ainslie, K. M. (2023). Distribution of Female and Male First and Last Authorship across Drug Delivery Related Journals with Respect to Year and Journal Impact Factor. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.3c00328

Vancouver

McLaughlin JE, Bachelder JM, Ainslie KM. Distribution of Female and Male First and Last Authorship across Drug Delivery Related Journals with Respect to Year and Journal Impact Factor. Molecular Pharmaceutics. 2023. doi:10.1021/acs.molpharmaceut.3c00328

BibTeX
@article{McLaughlin2023,
  author = {McLaughlin, Jacqueline E and Bachelder, Jacob M and Ainslie, Kristy M},
  title = {Distribution of Female and Male First and Last Authorship across Drug Delivery Related Journals with Respect to Year and Journal Impact Factor},
  journal = {Molecular Pharmaceutics},
  year = {2023},
  doi = {10.1021/acs.molpharmaceut.3c00328}
}
Kostenlos starten →